文献速递临床免疫临床生化

巨维生素B12:被低估的威胁

Macro vitamin B12: an underestimated threat.
PubMed 文献 · Clin Chem Lab Med · 2020-01-01

该研究评估免疫分析法是否受巨B12干扰,并在健康志愿者中验证聚乙二醇(PEG)沉淀流程。结果显示高B12样本中巨B12患病率高,建议对B12升高样本系统筛查巨B12以避免误诊。

要点

  • 高B12样本中巨B12患病率较高,不可忽视。
  • PEG沉淀法可用于筛查巨B12干扰。
  • 建议对B12升高样本系统筛查巨B12。

核心结论

  • 高B12样本中巨B12患病率高,建议用PEG沉淀法系统筛查以避免误诊或有害临床后果。

研究设计与样本

  • 随机选取50份B12极高(>1476 pmol/L)血清筛查巨B12干扰。
  • 健康志愿者及PEG上清用Cobas免疫分析,患者样本用Cobas和Architect免疫分析,疑似巨B12样本用尺寸排阻色谱(SEC)确认。

主要发现

  • 健康志愿者在Cobas 8000上PEG沉淀后回收率为68.3%至108.4%。
  • 健康志愿者在Cobas 8000上PEG沉淀后参考区间为122.1至514.4 pmol/L。
  • Architect i2000免疫分析也受巨B12影响。
  • SEC证实巨B12为免疫球蛋白-B12复合物。

关键数值与推荐

  • B12升高定义为>1476 pmol/L。
  • PEG沉淀后参考区间标准下巨B12阳性率为18%(9/50)。

临床怎么用

  • 对B12水平升高(>1476 pmol/L)的样本,采用PEG沉淀流程系统筛查巨B12。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background The correct identification of the macro-B12 interference (macroforms) is paramount to avoid potential erroneous clinical decisions. Our objectives were to determine whether immunoassays are affected by the presence of macro-B12 and to validate a polyethylene glycol (PEG) precipitation procedure to detect it. Methods Sixty-two serum samples obtained from healthy volunteers were analyzed to determine recovery and reference intervals (RIs) following PEG precipitation. Thereafter, 50 serum samples with very high levels of B12 (>1476 pmol/L) were randomly selected to search for macro-B12 interferences. Serum samples obtained from healthy volunteers and related PEG aliquots were analyzed on a Cobas® immunoassay. Patients' samples were analyzed on both Cobas® and Architect® immunoassays. Finally, samples suspected to contain macro-B12 were analyzed by size-exclusion chromatography (SEC) to confirm the presence of macro-B12. Results Recovery and post-PEG RIs determined on a Cobas 8000® in healthy volunteers ranged from 68.3% to 108.4% and from 122.1 to 514.4 pmol/L, respectively. Fifteen samples (30%) were found to show macro-B12 while using the recovery criteria, and nine samples (18%) while using the post-PEG RI. The other immunoassay ran on the Architect i2000® was also affected by the presence of macro-B12. Size-exclusion chromatography studies confirmed the presence of macro-B12 (immunoglobulin-B12 complexes). Conclusions The prevalence of macro-B12 in elevated B12 samples is high. We suggest to systematically screen for the presence of macro-B12 with PEG precipitation procedure in samples with elevated B12 levels to avoid potential misdiagnosis or harmful clinical consequences.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Soleimani R, Favresse J, Roy T, et al. Macro vitamin B12: an underestimated threat. Clin Chem Lab Med. 2020. PMID: 31665115. doi:10.1515/cclm-2019-0999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。